Detalles de la búsqueda
1.
Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels.
Scand J Clin Lab Invest
; 79(4): 260-267, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982358
2.
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
Int J Biol Markers
; 24(3): 147-55, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19787625
3.
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
Int J Biol Markers
; 24(3): 119-29, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19787622
4.
Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis.
Int J Biol Markers
; 31(3): e317-23, 2016 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26954072
5.
Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
Int J Biol Markers
; 26(4): 241-6, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22180173
6.
Testosterone and biological characteristics of breast cancers in postmenopausal women.
Cancer Epidemiol Biomarkers Prev
; 18(11): 2942-8, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19843675
7.
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clin Chem Lab Med
; 46(5): 588-99, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18598201
8.
Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clin Chem Lab Med
; 46(5): 600-11, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18598202
9.
Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clin Chem Lab Med
; 46(5): 612-22, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18598203
10.
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer.
Breast Cancer Res Treat
; 101(3): 355-65, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16850247
Resultados
1 -
10
de 10
1
Próxima >
>>